询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
(E)-2-Pentene | CAS:646-04-8
(E)-2-Pentene
  • 名称:(E)-2-戊烯 | (E)-2-Pentene
  • CAS号:646-04-8
  • 别名:2,5-Dihydroxyphenylacetic acid; Alcapton; Homogentisic acid; Homogentisinic acid; NSC 88940
  • 分子式:C5H10
  • 分子量:70.13
  • EINESC号:211-461-4

产品描述

物理化学性质

熔点 -138 ºC**
沸点 36.39 ºC (760 Torr)**
闪点 -45.6±0.0 ºC, 计算值*
密度 0.65551 g/cm3 (15 ºC)**
折射率 1.3899 (589.3 nm 5.3 ºC)**

安全数据

没有数据没有数据

SDS

来源 SDS样本
没有数据没有数据
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
In vitro potentiation of cephalosporins by alafosfalin against urinary tract bacteria.M Arisawa et al.Antimicrobial agents and chemotherapy, 21(5), 706-710 (1982-05-01) Genetic characterization and molecular cloning of the tripeptide permease (tpp) genes of Salmonella typhimurium.M M Gibson et al.Journal of bacteriology, 160(1), 122-130 (1984-10-01) The fractional inhibitory concentration (FIC) index as a measure of synergy.M J Hall et al.The Journal of antimicrobial chemotherapy, 11(5), 427-433 (1983-05-01) Antibacterial properties of alafosfalin combined with cephalexin.F R Atherton et al.Antimicrobial agents and chemotherapy, 20(4), 470-476 (1981-10-01) Pharmacokinetics of alafosfalin, alone and in combination with cephalexin, in humans.J G Allen et al.Antimicrobial agents and chemotherapy, 17(6), 973-979 (1980-06-01) Synergistic antibacterial activity between L-norvalyl-L-1-aminoethylphosphonic acid and nocardicin A.P Angehrn et al.Antimicrobial agents and chemotherapy, 25(5), 607-611 (1984-05-01) Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania.K J Towner et al.Bulletin of the World Health Organization, 58(5), 747-751 (1980-01-01) Alafosfalin as a selective agent for isolation of salmonella from clinical samples.J D Perry et al.Journal of clinical microbiology, 40(11), 3913-3916 (2002-11-01) Antibacterial activity of phosphono dipeptides related to alafosfalin.B Lejczak et al.Journal of medicinal chemistry, 29(11), 2212-2217 (1986-11-01) Effect of food on the bioavailability of alafosfalin, a new antibacterial agent.P G Welling et al.The Journal of antimicrobial chemotherapy, 6(3), 373-379 (1980-05-01) Phosphonopeptides, a new class of synthetic antibacterial agents.J G Allen et al.Nature, 272(5648), 56-58 (1978-03-02) Penetration of alafosfalin and ampicillin into tissue cage fluid in rabbits.C Henning et al.Chemotherapy, 28(3), 185-188 (1982-01-01) Recent developments in the field of phosphonic acid antibiotics.M Neuman The Journal of antimicrobial chemotherapy, 14(4), 309-311 (1984-10-01) Phosphonopeptides as antibacterial agents: mechanism of action of alaphosphin.F R Atherton et al.Antimicrobial agents and chemotherapy, 15(5), 696-705 (1979-05-01) Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis, and structure-activity relationships.F R Atherton et al.Antimicrobial agents and chemotherapy, 18(6), 897-905 (1980-12-01) Activity of a peptidyl prodrug, alafosfalin, against anaerobic bacteria.S F Grappel et al.Antimicrobial agents and chemotherapy, 27(6), 961-963 (1985-06-01) In vitro evaluation of alaphosphin (Ro 03-7008) against Serratia marcescens.W H Traub Chemotherapy, 26(2), 103-110 (1980-01-01) Alafosfalin, a new synthetic antibacterial compound.F E Hahn Die Naturwissenschaften, 68(2), 90-90 (1981-02-01) [Antibiotics of the phosphonic acid group].M S Poliak Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology, 32(1), 66-75 (1987-01-01) Transport of the phosphonodipeptide alafosfalin by the H+/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells.Jana Neumann et al.European journal of biochemistry, 271(10), 2012-2017 (2004-05-07) Synthesis and structure-activity relationships of antibacterial phosphonopeptides incorporating (1-aminoethyl)phosphonic acid and (aminomethyl)phosphonic acid.F R Atherton et al.Journal of medicinal chemistry, 29(1), 29-40 (1986-01-01)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交